Wells Fargo’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Hold
0
6859
2025
Q4
Sell
-1
Closed -$37 6839
2025
Q3
$30 Hold
1
﹤0.01% 6600
2025
Q2
$28 Buy
+1
New +$35 ﹤0.01% 6699
2025
Q1
Hold
0
6709
2024
Q4
Sell
-1
Closed -$39 6899
2024
Q3
$24 Buy
+1
New +$36 ﹤0.01% 6508
2024
Q2
Sell
-1
Closed -$35 6549
2024
Q1
$28 Hold
1
﹤0.01% 7003
2023
Q4
$33 Hold
1
﹤0.01% 7044
2023
Q3
$30 Buy
+1
New +$32 ﹤0.01% 7062
2023
Q2
Hold
0
7457
2023
Q1
Hold
0
7514

Other funds holding BOUT

Wells Fargo's BOUT Position: Q1 2026 in Review

Wells Fargo held its CapForce IBD Breakout Opportunities ETF (BOUT) position steady in Q1 2026 at 0 shares worth $15. The position accounts for ﹤0.01% of the portfolio, ranked #6859.

Wells Fargo first reported a position in BOUT in Q3 2023 and has held it in 6 quarters since. The position peaked at $33 in Q4 2023. 14 funds tracked by Wall St. Rank hold BOUT as of Q1 2026.

  • Wells Fargo held 0 shares of CapForce IBD Breakout Opportunities ETF worth $15 as of Q1 2026.
  • Wells Fargo left its CapForce IBD Breakout Opportunities ETF share count unchanged in Q1 2026.
  • CapForce IBD Breakout Opportunities ETF made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6859 holding.
  • Wells Fargo first reported a position in CapForce IBD Breakout Opportunities ETF in Q3 2023 and has held it in 6 quarters since.
  • Wells Fargo's CapForce IBD Breakout Opportunities ETF position peaked at $33 in Q4 2023.
  • 14 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.